Progyny (PGNY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
The annual meeting will be held virtually on May 21, 2026, with stockholders able to participate online and vote on key proposals.
Proxy materials and the annual report are available online, with voting accessible via internet, phone, or mail.
Only stockholders of record as of March 27, 2026, are eligible to vote.
Voting matters and shareholder proposals
Proposals include electing three Class I directors, ratifying Ernst & Young LLP as auditor, approving executive compensation (say-on-pay), and amending the Certificate of Incorporation to eliminate certain supermajority voting requirements.
Shareholders will also vote on eliminating the default supermajority voting requirement for certain business combinations.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
The board consists of ten members divided into three classes with staggered three-year terms.
Eight directors are independent under Nasdaq standards; the CEO and Executive Chairman are not.
Board leadership includes an executive chairman and a lead independent director.
Committees include audit, compensation, and nominating/governance, all composed of independent directors.
Board and committees met regularly, with high attendance and executive sessions held.
Latest events from Progyny
- Early renewals, strong sales, and new products drive growth and expand market reach.PGNY
Canaccord Genuity's 46th Annual Growth Conference - Record Q2 2026 revenue, profit, and margin growth, with strong outlook and share repurchases.PGNY
Q2 2026 - Record revenue, strong retention, and all proposals approved; poised for growth in 2026.PGNY
AGM 2026 - Robust demand, high retention, and product expansion position the business for sustained growth.PGNY
Bank of America Global Healthcare Conference 2026 - Q1 revenue up 12.2% (ex-large client), net income up 61%, and 8.8M shares repurchased.PGNY
Q1 2026 - Votes will address director elections, auditor ratification, and governance amendments.PGNY
Proxy filing - Key votes include director elections, auditor ratification, and reducing supermajority voting thresholds.PGNY
Proxy filing - Aiming for $2.4B+ revenue and $500M+ Adjusted EBITDA by 2028, leveraging new products and expansion.PGNY
Investor Day 2024 - Record Q1 revenue, double-digit EBITDA growth, and raised guidance amid strong demand.PGNY
Q1 2025